Evidence map›Paper›PMID 27479925›Full record

ArticleLetters in applied microbiology2016

Evaluation of the ability of Acinetobacter baumannii to form biofilms on six different biomedical relevant surfaces.

C Greene, J Wu, A H Rickard, C Xi

Abstract read
In one paragraph

Article in Letters in applied microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Food science and biotechnology · 2026
    Review
  3. Article
  4. Clonal lineage and biofilm growth shape cefiderocol activity inFrontiers in cellular and infection microbiology · 2026
    Article
  5. Article
  6. Article
  7. Multidrug resistantCurrent research in microbial sciences · 2025
    Review
  8. Article
  9. Comprehensive Approaches to CombattingAntibiotics (Basel, Switzerland) · 2024
    Review
  10. Fluopsin C Promotes Biofilm Removal of XDRAntibiotics (Basel, Switzerland) · 2024
    Article
  11. Review
  12. Article
  13. Exploring the occurrence ofFrontiers in microbiology · 2024
    Article
  14. Review
  15. Article
  16. Treatment and Management ofInfection and drug resistance · 2024
    Review
  17. Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategies.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Review
  18. Synergistic Role of Biofilm-Associated Genes and Efflux Pump Genes in Tigecycline Resistance of Acinetobacter baumannii.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  19. Article
  20. Phenotypic and genomic comparison of dominant and nondominant sequence-type ofFrontiers in cellular and infection microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

C GreeneDepartment of Environmental Health and Science, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0001-8058-1391
J WuDepartment of Environmental Health and Science, University of Michigan, Ann Arbor, MI, USA.
A H RickardDepartment of Epidemiology, University of Michigan, Ann Arbor, MI, USA.
C XiDepartment of Environmental Health and Science, University of Michigan, Ann Arbor, MI, USA. cxi@umich.edu.

Funding

Interdisciplinary Training Program in Infectious DiseasesT32AI049816 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FOXMAN, BETSY · 2002 to 2011
$1.5M
Extracellular ATP in biofilm formation and wound infectionR01GM098350 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI XI, CHUANWU · 2011 to 2015
$1.4M
NIAID NIH HHS T32 AI049816NIGMS NIH HHS R01 GM098350
6 · The paper itself

Abstract

unlabelledThe human opportunistic pathogen, Acinetobacter baumannii, has the propensity to form biofilms and frequently cause medical device-related infections in hospitals. However, the physio-chemical properties of medical surfaces, in addition to bacterial surface properties, will affect colonization and biofilm development. The objective of this study was to compare the ability of A. baumannii to form biofilms on six different materials common to the hospital environment: glass, porcelain, stainless steel, rubber, polycarbonate plastic and polypropylene plastic. Biofilms were developed on material coupons in a CDC biofilm reactor. Biofilms were visualized and quantified using fluorescent staining and imaged using confocal laser scanning microscopy (CLSM) and by direct viable cell counts. Image analysis of CLSM stacks indicated that the mean biomass values for biofilms grown on glass, rubber, porcelain, polypropylene, stainless steel and polycarbonate were 0·04, 0·26, 0·62, 1·00, 2·08 and 2·70 μm(3) /μm(2) respectively. Polycarbonate developed statistically more biofilm mass than glass, rubber, porcelain and polypropylene. Viable cell counts data were in agreement with the CLSM-derived data. In conclusion, polycarbonate was the most accommodating surface for A. baumannii ATCC 17978 to form biofilms while glass was least favourable. Alternatives to polycarbonate for use in medical and dental devices may need to be considered. SIGNIFICANCE AND IMPACT OF THE STUDY: In the hospital environment, Acinetobacter baumannii is one of the most persistent and difficult to control opportunistic pathogens. The persistence of A. baumannii is due, in part, to its ability to colonize surfaces and form biofilms. This study demonstrates that A. baumannii can form biofilms on a variety of different surfaces and develops substantial biofilms on polycarbonate - a thermoplastic material that is often used in the construction of medical devices. The findings highlight the need to further study the in vitro compatibility of medical materials that could be colonized by A. baumannii and allow it to persist in hospital settings.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsBiofilmsCeramicsColony Count, MicrobialEquipment and SuppliesGlassHospitalsHumansMicroscopy, ConfocalOpportunistic InfectionsPolymersPolypropylenesRubberStainless SteelSurface PropertieslexanPolymersPolypropylenesRubberStainless SteelAcinetobacter baumanniiBiofilmsenvironmentenvironmental surfacesinfection controlmedical device

Identifiers

PMID27479925
PMCPMC7057210

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.